Firm at a glance
Tesi is a platform private equity firm headquartered in Helsinki, per its own website [S1]. The firm reports approximately 3.2 billion EUR in assets under management as of July 2026 [S2].
What they buy
Public transaction records from the first half of 2026 show Tesi acquiring businesses across technology and industrial sectors. Recent disclosed investments include CurifyLabs, Savox, and Cactos, all completed within a concentrated timeframe in June and July 2026 [S1]. The firm appears to maintain an active deal pipeline with multiple platform acquisitions occurring in close succession.
Portfolio
Tesi’s publicly disclosed portfolio companies were not enumerated in available sources as of July 2026. The firm’s website references a portfolio section but specific holdings beyond recent transactions were not detailed in the materials reviewed [S2].
Recent activity (last 24 months)
– **July 2026**: Acquired CurifyLabs [S1]
– **July 2026**: Exited IQM [S1]
– **June 2026**: Acquired Savox [S1]
– **June 2026**: Acquired Cactos [S1]
How this firm fits a seller
Tesi’s transaction history in mid-2026 demonstrates both acquisition and exit activity, suggesting an active portfolio management approach. The firm’s Helsinki headquarters positions it as a regional investor for Nordic and European businesses seeking capital partners familiar with local market dynamics. The simultaneous exit from IQM alongside multiple new platform acquisitions indicates ongoing fund deployment and portfolio turnover. Sellers in technology and industrial sectors with European operations may find alignment with Tesi’s observed investment pattern, though the firm’s specific buy-box criteria were not publicly detailed in available materials.
Sources
[S1] https://tesi.fi (as of 2026-07-06)
[S2] https://tesi.fi/portfolio/ (as of 2026-07-06)
Frequently asked questions
Does Tesi buy technology businesses?
Recent public transactions suggest Tesi invests in technology companies, with CurifyLabs acquired in July 2026 and an exit from IQM completed the same month [S1]. The firm’s portfolio section indicates technology represents at least a portion of its investment focus, though specific sector allocations were not disclosed in available materials [S2].
What companies has Tesi acquired recently?
Tesi completed acquisitions of CurifyLabs, Savox, and Cactos between June and July 2026, per its website [S1]. These three platform investments occurred within approximately two weeks, indicating concentrated deal activity during this period.
Where is Tesi based and how big is the firm?
Tesi operates from Helsinki and reports approximately 3.2 billion EUR in assets under management as of July 2026 [S1][S2]. Public sources did not indicate additional office locations beyond the Helsinki headquarters.
Is Tesi still actively acquiring?
Yes, Tesi completed three separate acquisitions in June and July 2026, with the most recent transaction (CurifyLabs) occurring in early July [S1]. This recent activity suggests ongoing deal execution and capital deployment as of mid-2026.
This profile is maintained by CT Acquisitions as an independent third-party reference. CT Acquisitions is not affiliated with, endorsed by, or a representative of the firm profiled. All facts sourced from publicly available materials as of the dates cited.